Table 1.
Characteristics of patients with COVID-19.
| All (n = 17,479) | Survivors (n = 16,385) | Non-survivors (n = 1,094) | p value | |
|---|---|---|---|---|
| Age, years (SD) | 41.8 (16.1) | 40.5 (15.3) | 61.8 (14.2) | <.0001 |
| 0–20, n (%) | 1,077 (6.2) | 1,070 (6.5) | 7 (0.6) | <.0001 |
| 21–40, n (%) | 7,601 (43.5) | 7,535 (46.0) | 66 (6.0) | <.0001 |
| 41–60, n (%) | 6,356 (36.4) | 5,997 (36.6) | 359 (32.8) | .012 |
| >60, n (%) | 2,445 (14.0) | 1,783 (10.9) | 662 (60.5) | <.0001 |
| Sex, n (%) | <.0001 | |||
| Male | 8,759 (50.1) | 8,120 (49.6) | 637 (58.2) | – |
| Female | 8,720 (49.9) | 8,263 (50.4) | 457 (41.8) | – |
| Hospital treatment, n (%) | 2,393 (13.7) | 1,429 (9.1) | 901 (82.4) | <.0001 |
| Supplemental oxygen, n (%) | 4,107 (23.5) | 3,252 (19.8) | 855 (78.2) | <.0001 |
| Comorbidities | ||||
| Diabetes, n (%) | 1,901 (10.9) | 1,529 (9.4) | 372 (34.1) | <.0001 |
| COPD, n (%) | 104 (0.6) | 80 (0.5) | 24 (2.2) | <.0001 |
| Asthma, n (%) | 308 (1.8) | 288 (1.8) | 20 (1.8) | .874 |
| HT, n (%) | 2,344 (13.5) | 1,908 (11.7) | 436 (39.9) | <.0001 |
| Heart disease, n (%) | 213 (1.2) | 154 (0.9) | 59 (5.4) | <.0001 |
| Obesity, n (%) | 2,016 (11.6) | 1,799 (11.0) | 217 (19.8) | <.0001 |
| Chronic kidney disease, n (%) | 250 (1.4) | 160 (1.0) | 90 (8.2) | <.0001 |
| Tobacco use, n (%) | 926 (5.3) | 868 (5.3) | 58 (5.3) | .990 |
| HIV, n (%) | 33 (0.2) | 31 (0.2) | 2 (0.2) | .960 |
| Symptoms | ||||
| Fever, n (%) | 10,176 (58.4) | 9,341 (57.1) | 835 (76.5) | <.0001 |
| Dry cough, n (%) | 12,125 (69.5) | 11,247 (68.8) | 878 (80.3) | <.0001 |
| Sore throat, n (%) | 5,331 (30.6) | 4,946 (30.3) | 385 (35.3) | .001 |
| Dyspnea, n (%) | 4,006 (23.0) | 3,175 (19.4) | 831 (76.0) | <.0001 |
| Diarrhea, n (%) | 2,454 (14.1) | 2,327 (14.2) | 127 (11.6) | .017 |
| Chest pain, n (%) | 2,958 (17.0) | 2,606 (15.9) | 352 (32.3) | <.0001 |
| Headache, n (%) | 13,125 (75.2) | 12,327 (75.4) | 798 (73.1) | .086 |
| Myalgia, n (%) | 8,020 (46.0) | 7,464 (45.7) | 556 (50.9) | .001 |
| Arthralgia, n (%) | 6,356 (36.5) | 5,826 (35.7) | 530 (48.5) | <.0001 |
| General malaise, n (%) | 5,673 (32.5) | 4,989 (30.5) | 684 (62.7) | <.0001 |
| Rhinorrhea, n (%) | 2,944 (16.9) | 2,776 (17.0) | 168 (15.4) | .175 |
| Polypnea, n (%) | 1,152 (6.6) | 850 (5.2) | 302 (27.7) | <.0001 |
| Vomiting, n (%) | 916 (5.3) | 844 (5.2) | 72 (6.6) | .040 |
| Abdominal pain, n (%) | 1,285 (7.4) | 1,197 (7.3) | 88 (8.1) | .364 |
| Conjunctivitis, n (%) | 871 (5.0) | 837 (5.1) | 34 (3.1) | .003 |
| Cyanosis, n (%) | 217 (1.2) | 160 (1.0) | 57 (5.2) | <.0001 |
| Anosmia, n (%) | 1,381 (9.1) | 1,337 (9.4) | 44 (4.6) | <.0001 |
SD: standard deviation; COPD: chronic obstructive pulmonary disease; HT: hypertension; HIV: human immunodeficiency virus.